Description de l’essai
Pan-NTRK fusions immuno-detection in various tumor types as a screening tool for larotectinib treatment eligibility. Larotectinib pan NTRK fusions immunodetection harmonization in France
Trial sponsor
CENTRE JEAN PERRIN
Médecin ICO - Angers
VERONIQUE VERRIELE
Type d'intervention évaluée
Analyse biologique
Date de début de l'essai
06/03/2020
